By: Eric Volkman, Chuck Saletta, Jason Hall
Key Points Starbucks is still seeing strong traffic, despite its earnings miss. Datadog's longer-term prospects look better than its short-term hiccup. Bristol Myers Squibb issued downbeat guidance for 2024 but looks reasonably priced based on its 2025 prospects. Motley Fool Issues Rare “All In” Buy Alert